THZ1 – 5 mg

Brand:
Cayman
CAS:
1604810-83-4
Storage:
-20
UN-No:
Non-Hazardous - /

THZ1 is a Cdk7 inhibitor (IC50s = 3.2-15.6 nM in vitro) that selectively targets a remote cysteine residue located outside of the classic kinase domain.{31732} THZ1 also targets Cdk12 kinase activity although at a higher concentration (IC50 = 250 nM).{31732} It displays broad anti-proliferative activity against cancer cell lines, particularly T-ALL cell lines that display characteristic misregulation of T cell lineage-specific transcription factors.{31732} THZ1 is reported to induce apoptotic cell death in triple-negative breast cancer cells that are highly dependent on Cdk7.{31733}  

 

Available on backorder

SKU: 9002215 - 5 mg Category:

Description

A covalent Cdk7 inhibitor (IC50s = 3.2-15.6 nM in vitro) that displays broad anti-proliferative activity against cancer cell lines, particularly T-ALL cell lines with characteristic misregulation of T cell lineage-specific transcription factors


Formal name: N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-benzamide

Synonyms: 

Molecular weight: 566.1

CAS: 1604810-83-4

Purity: ≥95%

Formulation: A crystalline solid